Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Stoof

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Neuroscience Letters|June 2, 1995
Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal developmentC H Langeveld, C A Jongenelen, E Schepens, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1994
Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of ratsF S Radhakishun, B H Westerink, J C Stoof, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1992
The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery intervalP De Boer, G Damsma, Q Schram, et al.
Brain Research. Developmental Brain Research|March 16, 1995
Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activityF L Van Muiswinkel, C A Jongenelen, H T Schepens, et al.
Synapse (New York, N.Y.)|July 1, 1994
Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptorsA N Schoffelmeer, F Hogenboom, A H Mulder, et al.
Brain Research|November 24, 1987
The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitroF S Radhakishun, J C Stoof, A H Mulder, et al.
European Journal of Pharmacology|April 22, 1993
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
European Journal of Pharmacology|September 2, 1987
9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ currentB Drukarch, K S Kits, E G Van der Meer, et al.
Journal of Neurosurgery|January 1, 1992
Hormone receptors and glioma cell growthC H Langeveld, J G Wolbers, J J Heimans, et al.
Behavioural Pharmacology|April 26, 2000
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297G Andringa, R J Vermeulen, B Drukarch, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Neuroscience Letters|June 2, 1995
Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal developmentC H Langeveld, C A Jongenelen, E Schepens, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 1994
Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of ratsF S Radhakishun, B H Westerink, J C Stoof, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1992
The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery intervalP De Boer, G Damsma, Q Schram, et al.
Brain Research. Developmental Brain Research|March 16, 1995
Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activityF L Van Muiswinkel, C A Jongenelen, H T Schepens, et al.
Synapse (New York, N.Y.)|July 1, 1994
Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptorsA N Schoffelmeer, F Hogenboom, A H Mulder, et al.
Brain Research|November 24, 1987
The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitroF S Radhakishun, J C Stoof, A H Mulder, et al.
European Journal of Pharmacology|April 22, 1993
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
European Journal of Pharmacology|September 2, 1987
9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ currentB Drukarch, K S Kits, E G Van der Meer, et al.
Journal of Neurosurgery|January 1, 1992
Hormone receptors and glioma cell growthC H Langeveld, J G Wolbers, J J Heimans, et al.
Behavioural Pharmacology|April 26, 2000
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297G Andringa, R J Vermeulen, B Drukarch, et al.
Pageof 12